NO980785L - Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene - Google Patents

Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene

Info

Publication number
NO980785L
NO980785L NO980785A NO980785A NO980785L NO 980785 L NO980785 L NO 980785L NO 980785 A NO980785 A NO 980785A NO 980785 A NO980785 A NO 980785A NO 980785 L NO980785 L NO 980785L
Authority
NO
Norway
Prior art keywords
compounds
sulfonamide
drug
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO980785A
Other languages
English (en)
Norwegian (no)
Other versions
NO980785D0 (no
Inventor
Joachim Brendel
Hans Jochen Lang
Uwe Gerlach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO980785D0 publication Critical patent/NO980785D0/no
Publication of NO980785L publication Critical patent/NO980785L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO980785A 1997-02-26 1998-02-25 Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene NO980785L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19707656A DE19707656A1 (de) 1997-02-26 1997-02-26 Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
NO980785D0 NO980785D0 (no) 1998-02-25
NO980785L true NO980785L (no) 1998-08-27

Family

ID=7821518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980785A NO980785L (no) 1997-02-26 1998-02-25 Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene

Country Status (25)

Country Link
EP (1) EP0861836B1 (xx)
JP (1) JP4171097B2 (xx)
KR (1) KR19980071625A (xx)
CN (1) CN1110490C (xx)
AR (1) AR011163A1 (xx)
AT (1) ATE286039T1 (xx)
AU (1) AU737461B2 (xx)
BR (1) BR9800207A (xx)
CA (1) CA2230349A1 (xx)
CZ (1) CZ53998A3 (xx)
DE (2) DE19707656A1 (xx)
ES (1) ES2234044T3 (xx)
HR (1) HRP980098A2 (xx)
HU (1) HUP9800395A3 (xx)
ID (1) ID19931A (xx)
IL (1) IL123454A0 (xx)
MX (1) MX9801516A (xx)
NO (1) NO980785L (xx)
NZ (1) NZ329838A (xx)
PL (1) PL325045A1 (xx)
RU (1) RU2223264C2 (xx)
SK (1) SK283312B6 (xx)
TR (1) TR199800301A2 (xx)
TW (1) TW452574B (xx)
ZA (1) ZA981562B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
WO2004043367A2 (en) 2002-11-06 2004-05-27 Bristol-Myers Squibb Company Fused heterocyclic compounds and use thereof
US20120309796A1 (en) * 2011-06-06 2012-12-06 Fariborz Firooznia Benzocycloheptene acetic acids
RU2538962C1 (ru) * 2013-11-19 2015-01-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Противогрибковые соединения на основе производных 3,5,8-триоксабицикло[5.1.0]октана

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
SK23998A3 (en) 1998-09-09
NZ329838A (en) 1999-07-29
JP4171097B2 (ja) 2008-10-22
JPH10287641A (ja) 1998-10-27
TR199800301A2 (xx) 1998-09-21
MX9801516A (es) 1998-11-30
CN1110490C (zh) 2003-06-04
HUP9800395A2 (hu) 2001-04-28
ES2234044T3 (es) 2005-06-16
SK283312B6 (sk) 2003-05-02
CA2230349A1 (en) 1998-08-26
HUP9800395A3 (en) 2002-04-29
EP0861836A1 (de) 1998-09-02
CN1193017A (zh) 1998-09-16
CZ53998A3 (cs) 1998-09-16
AU5633398A (en) 1998-09-03
DE19707656A1 (de) 1998-08-27
HRP980098A2 (en) 1998-12-31
KR19980071625A (ko) 1998-10-26
ZA981562B (en) 1998-08-26
AR011163A1 (es) 2000-08-02
RU2223264C2 (ru) 2004-02-10
ATE286039T1 (de) 2005-01-15
EP0861836B1 (de) 2004-12-29
ID19931A (id) 1998-08-27
AU737461B2 (en) 2001-08-23
TW452574B (en) 2001-09-01
DE59812423D1 (de) 2005-02-03
BR9800207A (pt) 1999-05-18
IL123454A0 (en) 1998-09-24
NO980785D0 (no) 1998-02-25
PL325045A1 (en) 1998-08-31
HU9800395D0 (en) 1998-04-28

Similar Documents

Publication Publication Date Title
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
HUP0203973A3 (en) Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
DK0789025T3 (da) Substituerede oxazolidinoner samt deres anvendelse som antibakterielle lægemidler
BR9814592B1 (pt) composto azapolicìclico condensado com arila, composição farmacêutica contendo o mesmo e seu uso na fabricação de um medicamento.
NO20032187D0 (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO324250B1 (no) Diazabicykliske forbindelser, farmasoytiske sammensetninger omfattende disse samt deres anvendelse
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
DK1222163T3 (da) 2'-Substituerede 1,1'-biphenyl-2-carboxamider, fremgangsmåder til fremstilling deraf, deres anvendelse som medikament samt farmaceutiske præparater, som indeholder dem
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
NO20030296L (no) Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene
NO20016247L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
BR9811582B1 (pt) compostos derivados de 4-oxo-3,5-di-hidro-4h-piridazino[4,5-b]indol-1-acetamid a, medicamento e composição farmacêutica contendo os mesmos.
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO984476L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO980785L (no) Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene
ATE260094T1 (de) Mikronisierte bicyclische arzneistoffe enthaltende pharmazeutische zusammensetzungen
NO985171D0 (no) Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO985023D0 (no) Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO20024590D0 (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
NO984475D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene